StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DRMA.JK$975.00+0.00%
Fair $975.00+0.0%

DRMA.JK

PT Dharma Polimetal Tbk

Consumer Cyclical / Auto PartsJakarta

$975.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $975.00Fund rank 29/100 · Data gapFallback financials|
SA 54/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 22%

FCF escenarios

weak_data · normalized FCF $405.7B · quality 49.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · DRMA.JKLocal privado en este navegador · PT Dharma Polimetal Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.59T

P/E

7.0x

↓

EV/EBITDA

4.8x

↓

ROE

23.5%

↑

Gross Margin

18.0%

↓

Debt/Equity

0.10

↓
52-Week Range$975
$915$1200

TradingView lightweight chart

DRMA.JK price, volumen y niveles de valoración

Último $975.00Periodo +96.6%
Fair value: $975.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+15.0%

FCF CAGR

—

FCF margin

10.3%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.94T · net income $652.58B · FCF $610.06B

2022-FY → 2025-FY

Gross margin

18.0%+2.3% pts

Operating margin

12.4%+1.2% pts

Net margin

11.0%+0.9% pts

FCF margin

10.3%+14.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$5939.68B$5939.68B$5507.65B$5541.17B$3905.42B
Net Income$652.58B$652.58B$579.29B$611.75B$394.17B
EBITDA$887.11B$887.11B$800.26B$819.28B$543.61B
EPS——123.00130.0084.00
Gross Margin18.0%18.0%18.2%17.6%15.7%
Operating Margin12.4%12.4%13.1%12.7%11.2%
Net Margin11.0%11.0%10.5%11.0%10.1%
Balance Sheet
Debt/Equity0.100.100.200.270.37
Current Ratio1.931.93———
Cash Flow
Free Cash Flow$610.06B$610.06B$219.56B$405.72B$-156.89B
Returns
ROE23.5%23.5%24.9%32.1%28.4%
Valuation
P/E6.966.967.3210.466.85
EV/EBITDA4.824.825.387.975.57
P/B1.651.651.823.361.95
Growth & Yield
Revenue Growth7.8%7.8%-0.6%41.9%—
EPS Growth——-5.4%54.8%—
Dividend Yield7.2%7.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +3.7%

Total return

+3.7%

Start / end P/E

n/dx → n/dx

EPS bridge

123.00 → n/d

Residual

-3.5%

EPS growthn/d
Multiple reratingn/d
Dividend+7.2%
Residual / FX / buybacks / cross-term-3.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.